AIR DNase™
PB-110-CF02
Phase 2 small_molecule active
Quick answer
AIR DNase™ for Cystic Fibrosis is a Phase 2 program (small_molecule) at Protalix BioTherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Protalix BioTherapeutics
- Indication
- Cystic Fibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active